MAI Capital Management’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$48.4K Sell
21,234
-12,632
-37% -$28.8K ﹤0.01% 1770
2025
Q1
$52.5K Sell
33,866
-294,460
-90% -$456K ﹤0.01% 1621
2024
Q4
$772K Sell
328,326
-913
-0.3% -$2.15K 0.01% 694
2024
Q3
$1.2M Sell
329,239
-4,761
-1% -$17.3K 0.01% 492
2024
Q2
$1.16M Sell
334,000
-20,306
-6% -$70.7K 0.01% 540
2024
Q1
$2.26M Buy
354,306
+2,400
+0.7% +$15.3K 0.02% 372
2023
Q4
$2.27M Sell
351,906
-17,574
-5% -$113K 0.03% 296
2023
Q3
$861K Sell
369,480
-32,016
-8% -$74.6K 0.01% 457
2023
Q2
$956K Sell
401,496
-32,169
-7% -$76.6K 0.01% 435
2023
Q1
$798K Sell
433,665
-48,987
-10% -$90.1K 0.01% 472
2022
Q4
$917K Buy
482,652
+123,542
+34% +$235K 0.02% 421
2022
Q3
$768K Sell
359,110
-6,297
-2% -$13.5K 0.01% 415
2022
Q2
$1.03M Buy
+365,407
New +$1.03M 0.02% 354